Single Versus Combination Medication Treatment for Children With Attention Deficit Hyperactivity Disorder (Project1)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00429273|
Recruitment Status : Completed
First Posted : January 31, 2007
Results First Posted : June 14, 2017
Last Update Posted : June 14, 2017
|Study Design||Allocation: Randomized; Intervention Model: Parallel Assignment; Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor); Primary Purpose: Treatment|
Attention Deficit Disorder With Hyperactivity
Drug: Methylphenidate (MPH)
212 randomized (deemed eligible and enrolled). 71 randomized to Group 1: 3 dropped prior to receiving drug; thus 68 started drug.
70 randomized to Group 2: 1 dropped before receiving drug; thus 69 started drug.
71 randomized to Group 3:1 dropped before receiving drug; thus 70 started drug.